Bank Of America Corp Alzamend Neuro, Inc. Transaction History

Bank Of America Corp

5 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q1 2023 May 12, 2023	SELL	$0.37 - $0.71 $17 - $32	-46 Reduced 14.84%	264 $0
Q4 2022 Feb 10, 2023	SELL	$0.53 - $222.0 $729 - $305,472	-1,376 Reduced 81.61%	310 $0
Q3 2022 Nov 14, 2022	SELL	$0.88 - $178.5 $5 - $1,071	-6 Reduced 0.35%	1,686 $2,000
Q2 2022 Aug 12, 2022	SELL	$0.82 - $1.2 $21,734 - $31,806	-26,505 Reduced 94.0%	1,692 $1,000
Q1 2022 May 16, 2022	BUY	$0.91 - $2.23 $25,659 - $62,879	28,197 New	28,197 $35,000

Ticker ALZN
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 95,481,800
Market Cap $159M
Description
Alzamend Neuro, Inc., an early clinical-stage biopharmaceutical company, focuses on developing various products for the treatment of neurodegenerative and psychiatric disorders. The company's pipeline includes AL001 that is in Phase II clinical trial, which delivers a therapeutic combination of lithium, proline, and salicylate for the treatment ...

Get notified when there are updates to the investment portfolio of Bank Of America Corp , based on Form 13F filings with the SEC.

Stay updated on Bank Of America Corp with notifications on news.